Table 4 Patients’ outcomes
Outcomes | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
DVT group (n = 47) | Non-DVT (n = 603) | P | DVT group (n = 47) | Non-DVT (n = 169) | P | |
28-day survival rate | 41 (87.2%) | 491 (81.4%) | 0.320 | 42 (87.2%) | 141 (83.4%) | 0.318 |
60-day survival rate | 38 (80.9%) | 476 (78.9%) | 0.756 | 38 (80.9%) | 137 (81.2%) | 0.765 |
ICU stay (days) | 12.0 (5.0–26.0) | 9.0 (5.0–17.0) | 0.400 | 12.0 (5.0–26.0) | 10.0 (6.0–25.0) | 0.360 |
Hospital stay (days) | 27.0 (12.0–43.0) | 18.0 (10.0–30.0) | 0.104 | 27.0 (12.0–43.0) | 20.0 (10.0–43.0) | 0.886 |
Pulmonary embolism within 60 days | 0 (0%) | 0 (0%) | – | 0 |  | – |
Bleeding events | 20 (42.6%) | 40 (6.6%) | < 0.001 | 20 (42.6%) | 15 (8.9%) | < 0.001 |
Coagulation disorders | 3 (6.4%) | 29 (4.8%) | 0.498 | 3 (6.4%) | 9 (5.3%) | 0.726 |